Chanelle McCoy Health Claims First Positive EFSA Opinion on CBD Novel Food Application
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
24 results for “health”
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
Clinicians, scientists and patients explored whether medical cannabis could help address longstanding inequalities in women’s health.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
A new policy model aims to integrate women’s health conditions into medical cannabis frameworks across Europe.
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid System (ECS)—a complex biological […]
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? […]
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
Jordan Stephens aims to shed light on the role of alternative treatments in supporting mental wellbeing.
Cannabis Health has partnered with experts at the Medical Cannabis Clinicians Society to host its first event for healthcare professionals.
Cannabis Health will host its first expert-led educational event for healthcare professionals later this year.
Ministers raised concerns related to the growing use among young people and potential risks to mental health.
Just months ago, France’s long battle to establish a permanent generalised medical cannabis framework was on the brink of failure. Despite other major European countries looking to France’s 2019 pilot […]
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing […]
After a six-year battle on behalf of campaigners, Romania’s Health Committee has rejected a bill which would broaden access to medical cannabis products on prescription. Following […]
Patients prescribed medicinal cannabis reported less fatigue and sleep disturbance over 12 months.
Researchers at the University of Edinburgh say CBD is a “promising therapeutic agent” due to its varying effects on the body.
In a report from November 2023, France’s Directorate General of Health (DGS) recommended the roll out of a temporary regulatory framework.